I once got a rejection on Christmas Day… won’t tell from which journal…

Cancer Trials Ireland Vice-Clinical Lead, @gerryhanna.bsky.social @tcddublin.bsky.social presenting on ‘The Future of Radiation Oncology Research’.

A wide-ranging presentation covering many critical topics in cancer research, including biomarkers, AI workflows, and radiomics.

#IRROG #CancerTrials

Gerry Hanna: IASLC Quiz Winner at WCLC25 - OncoDaily Gerry Hanna: IASLC Quiz Winner at WCLC25 / cancer, Fiona McDonald, Gerry Hanna, Houda Bahig, OncoDaily, Oncology, Sara Ramella, Stephen Liu, World

IASLC Quiz Winner at WCLC25 - Gerry Hanna

@gerryhanna.bsky.social @iaslc.bsky.social

oncodaily.com/voices/gerry...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #WCLC25

Drew Moghanaki and Gerry Hanna Discuss Survival and Toxicity of New Phase 3 Trial in LS-SCLC - OncoDaily Drew Moghanaki and Gerry Hanna Discuss Survival and Toxicity of New Phase 3 Trial in LS-SCLC / cancer, Drew Moghanaki, Gerry Hanna, LS-SCLC, OncoDaily, Oncology

Drew Moghanaki and Gerry Hanna Discuss Survival and Toxicity of New Phase 3 Trial in LS-SCLC

@drewmoghanaki.bsky.social @gerryhanna.bsky.social

oncodaily.com/voices/drew-...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #SCLC #LungCancer

@uksabr.bsky.social is coming to Newcastle!
Save the dates: Annual Professional Conference and pre-conference lung workshop. Wed 19, Thurs 20 & Fri 21 Nov. More details bit.ly/3Zh2YVj - there is no other event like it. @gerryhanna.bsky.social @drpeedell.bsky.social @marina-khan.bsky.social

Australia's deadliest cancer to get new screening program After years of lobbying from patients, the first ever national lung cancer screening program will roll out next month for people who have a significant history of smoking.

🙏🏽 ABC for shining the light on 🇦🇺 deadliest cancer. Bring on #lungcancer screening www.abc.net.au/news/2025-06... @abcnewsbot.bsky.social @gerryhanna.bsky.social @drtomjohn.bsky.social @dkarikios.bsky.social @bensolomon1.bsky.social

ACR Appropriateness Criteria® Lung Cancer-Surveillance After Therapy This document reviews the evidence supporting different imaging modalities and techniques used to evaluate patients with a history of lung cancer. It …

Guidance on appropriate imaging in FU after #lungcancer Rx. Highly variable in practice. Time for #commonsenseoncology www.sciencedirect.com/science/arti... @iaslc.bsky.social @astro-org.bsky.social @gerryhanna.bsky.social @drtomjohn.bsky.social @dkarikios.bsky.social @hannaradonc.bsky.social

@gerryhanna.bsky.social off to a strong start debating about the management of stage III NSCLC in the IO era: knife or beam.
#ESTRO25

Gerry Hanna: Highly Impactful Opening Address at ESTRO 2025 - OncoDaily Gerry Hanna: Highly Impactful Opening Address at ESTRO 2025 / cancer, ESTRO 2025, Gerry Hanna, OncoDaily, Oncology

Highly Impactful Opening Address at ESTRO 2025 - Gerry Hanna
@gerryhanna.bsky.social
@mguckenberger.bsky.social
@estroradiotherapy.bsky.social

oncodaily.com/blog/gerry-h...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ESTRO25 #ESTRO2025

Excellent talk from @sarahbarrett-1.bsky.social outlining pioneering trends in #lung cancer #radiotherapy. Changing #OARs, #Dose optimisation and #personalisation @gerryhanna.bsky.social @leechmmichelle.bsky.social

Really delighted and grateful to be elected to a professorial fellowship at @tcddublin.bsky.social

Huge gratitude to my colleagues, collaborators and friends who have supported me over the years, but huge 🙏 to Suzie and my family ❤️
@leechmmichelle.bsky.social @qubelfastofficial.bsky.social

Validation of a Fully Automated Hybrid Deep Learning Cardiac Substructure Segmentation Tool for Contouring and Dose Evaluation in Lung Cancer Radiotherapy - PubMed The novel hybrid automatic segmentation tool reported high accuracy and consistency over a validation set with challenging anatomical and imaging variations. This has promising applications in substru...

👏🏽🎉Dr Vicky Chin on being awarded the Frank Ellis medal for greatest contribution to advancing the science of cancer
treatment in 2023 Clinical Oncology. pubmed.ncbi.nlm.nih.gov/36964031/ @unsw.bsky.social @gerryhanna.bsky.social #Cardiooncology #PhD

💡 Investment in clinical trials is key to advancing cancer care in Ireland. Sustained funding can boost research, patient safety & innovation. @gerryhanna.bsky.social explains why a centralised approach is needed. Read more 👉 bit.ly/4iPTzMp

#ClinicalTrials2025 #HealthcareInnovations2025

Sunshine and shimmery sand where the Mountains of Mourne sweep down to the sea.

Beautiful today in #Newcastle Co. Down

Join us on March 24th at 12pm Dublin time for a fascinating presentation by Roisín O'Maolalaí, IRROG manager, on developing a clinical trials network in #radonc in Ireland. Register at: tcd-ie.zoom.us/webinar/regi... or scan the QR code. #CPD #radther #radiationtherapy

Real privilege to have Prof Marcel Van Herk from The Christie and @cruk-mi.bsky.social in @qubelfastofficial.bsky.social today

Great to discuss the optimisation of radiotherapy and how #bigdata may help

Trust is essential for cooperation/coordination/performance at work. Trust is a dynamic process, not static, fuelled by reciprocity: people responding to positive actions with other positive actions sfu.ca/complex-syst.... By simonfraseru.bsky.social. Indepth: onlinelibrary.wiley.com/doi/10.1002/...

Well #BTOG25 that’s a wrap for 2025 from #Belfast

Thanks to @btog.bsky.social for 3 fantastic years in Belfast

It’s been an absolute pleasure to have the BTOG community over with us for the last 3 years 🙏

Here’s to next year in Edinburgh!
@drsanjaypopat.bsky.social
@tnewsomdavis.bsky.social

Although @stephenvliu.bsky.social is hard to follow, we’ve just had an absolute tour de force by @drjnaidoo.bsky.social at #BTOG25 on #SCLC

➡️ Discusses NRG005 and the better outcomes for patients reviving twice daily radiotherapy.

➡️ Continued evidence of a benefit from PCI in LS-SCLC

Great session on systemic therapy for SCLC by @stephenvliu.bsky.social at #BTOG23

➡️ BiTE engages, ADCs and many other agents showing promise
➡️ Possible role for radioligands
➡️ New never smokers phenotype emerging
➡️ Many reasons to be hopeful!

@drjnaidoo.bsky.social
@tnewsomdavis.bsky.social

Ama amazing and packed session. Bravo to speakers and chairs! @btog.bsky.social #BTOG25

Always sunny in #Belfast!

Riyaz Shah and Gerry Hanna are chairing the next session on Stage II-III NSCLC with Solange Peters, Yannis Perentes and Houda Bahig speaking #BTOG25

My takeaways 👇

➡️ uncertainty regarding benefit of peri-operative vs pre-op ChemoIO
➡️ EORTC guidelines give us a steer on surgical resectability
➡️ Radiotherapy and CRT being using post pre-op ChemoIO if patient no longer operable
➡️ Role of PORT needs re-examined in higher risk disease

#BTOG25

Delighted to chair the Stage 2/3 #NSCLC session alongside the brilliant Dr Riyaz Shah at #BTOG25 in #Belfast

3 superb presentations from Prof Peters Solange, Prof Jean Yannis Perentes and Dr Houda Bahig

Great discussion afterwards

Fantastic over of #radiation induced pneumonitis by #ESTRO President @mguckenberger.bsky.social at #BTOG25

Updates the congress on the new #ESTRO guidelines in this area

@drjnaidoo.bsky.social @drpeedell.bsky.social

Some great discussion points below 👇

Great to have Prof Matt Evison giving the opening talk in the #radiotherapy session at #BTOG25, with @mguckenberger.bsky.social

Follow-up after lung cancer treatment…when, who, where….?

Quick question to the #BTOG25 Captain @tnewsomdavis.bsky.social

Is @bsky.app the preferred social media channel?

Asking for a friend…

Also looking forward to seeing @drpeedell.bsky.social ‘s 🕺moves

#murderonthedancefloor

Looking forward to it @drsanjaypopat.bsky.social

Welcome to #Belfast!